|
TTC35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.062620E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.750700E-04 |
| Normal-vs-Stage2 |
1.488040E-01 |
| Normal-vs-Stage3 |
7.585900E-02 |
| Normal-vs-Stage4 |
8.955600E-01 |
| Stage1-vs-Stage2 |
3.374400E-01 |
| Stage1-vs-Stage3 |
4.613800E-01 |
| Stage1-vs-Stage4 |
8.070400E-02 |
| Stage2-vs-Stage3 |
7.665800E-01 |
| Stage2-vs-Stage4 |
3.123200E-01 |
| Stage3-vs-Stage4 |
2.274200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.421460E-03 |
| Normal-vs-AfricanAmerican |
1.491950E-02 |
| Normal-vs-Asian |
8.966400E-01 |
| Caucasian-vs-AfricanAmerican |
9.465800E-01 |
| Caucasian-vs-Asian |
3.689400E-01 |
| AfricanAmerican-vs-Asian |
5.972800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.227200E-04 |
| Normal-vs-Female |
8.642200E-02 |
| Male-vs-Female |
5.904400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.815600E-03 |
| Normal-vs-Extreme_Weight |
2.385000E-03 |
| Normal-vs-Obese |
5.859700E-02 |
| Normal-vs-Extreme_Obese |
1.437990E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.222000E-01 |
| Normal_Weight-vs-Obese |
3.493400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.519400E-01 |
| Extreme_Weight-vs-Obese |
3.070200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.024600E-01 |
| Obese-vs-Extreme_Obese |
5.404200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.704200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.519400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.764100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.603700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.040430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.510000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.285400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.770420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.929400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.439600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.829500E-04 |
| Normal-VS-Type2 PRCC |
9.321700E-03 |
| Normal-VS-KIRP CIMP |
7.444200E-01 |
| Normal-VS-Unclassified PRCC |
1.884280E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.993400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.039600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.137000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.501200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.798200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.173000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.640100E-03 |
| Normal-vs-N1 |
6.815600E-01 |
| Normal-vs-N2 |
6.462000E-01 |
| N0-vs-N1 |
9.302100E-02 |
| N0-vs-N2 |
4.766600E-01 |
| N1-vs-N2 |
9.109200E-01 |
|
|
